Yasir Y Elamin, MD
Department of Thoracic-Head & Neck Med Onc, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Postgraduate Training
| 2015-2017 | Clinical Fellowship, Medical Oncology, MD Anderson Cancer Center, Houston, TX |
| 2013-2015 | Clinical Fellowship, Medical Oncology, Beaumont Hospital, Dublin |
| 2011-2013 | Clinical Fellowship, Medical Oncology, St James's University Hospital, Dublin |
| 2009-2011 | Clinical Residency, Internal Medicine, Galway University Hospital, Galway |
Honors & Awards
| 2015 | American Society of Clinical Oncology (ASCO) Young Investigator Award (YIA) |
| 2015 | American Society of Clinical Oncology (ASCO) Merit Award |
Selected Publications
Peer-Reviewed Articles
- Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV. STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. Cancer Discov 8(7):822-835, 2018. e-Pub 2018. PMID: 29773717.
- Robichaux JP, Elamin YY, Tan Z, Carter BW, Zhang S, Liu S, Li S, Chen T, Poteete A, Estrada-Bernal A, Le AT, Truini A, Nilsson MB, Sun H, Roarty E, Goldberg SB, Brahmer JR, Altan M, Lu C, Papadimitrakopoulou V, Politi K, Doebele RC, Wong KK, Heymach JV. Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer. Nat Med 24(5):638-646, 2018. e-Pub 2018. PMID: 29686424.
- Holla VR, Elamin YY, Bailey AM, Johnson AM, Litzenburger BC, Khotskaya YB, Sanchez NS, Zeng J, Shufean MA, Shaw KR, Mendelsohn J, Mills GB, Meric-Bernstam F, Simon GR. ALK: a tyrosine kinase target for cancer therapy. Cold Spring Harb Mol Case Stud 3(1):a001115, 2017. PMID: 28050598.
- Elamin YY, Rafee S, Osman N, O Byrne KJ, Gately K. Thymidine Phosphorylase in Cancer; Enemy or Friend?. Cancer Microenviron 9(1):33-43, 2016. e-Pub 2015. PMID: 26298314.
- Elamin YY , Rafee S, Toomey S, Hennessy BT. Immune effects of bevacizumab: killing two birds with one stone. Cancer Microenviron 8(1):15-21, 2015. e-Pub 2014. PMID: 25326055.
- Rafee S, Elamin YY, Joyce E, Toner M, Flavin R, McDermott R, Sheehy N, Hennessy B, O'Byrne K, Gleeson N, Osman N. Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement. Tumori 101(2):e35-9, 2015. e-Pub 2015. PMID: 25744866.
- Osman N, Elamin YY, Rafee S, O'Brien C, Stassen LF, Timon C, Kinsella J, Brennan S, O'Byrne KJ. Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience. Eur Arch Otorhinolaryngol 271(8):2253-9, 2014. PMID: 24121822.
- Shikhrakab H, Elamin YY, O'Brien C, Gately K, Finn S, O'Byrne K, Osman N. Epidermal growth factor receptor (EGFR) mutation testing, from bench to practice: a single institute experience. Ir Med J 107(7):201-4, 2014. PMID: 25226713.
- Rafee S, Elamin YY, Cronin K, Brennan S, Osman N. A rare case of nasopharyngeal carcinoma with widespread CNS metastases. Ir Med J 107(6):180-1, 2014. PMID: 24988837.
Grant & Contract Support
| Title: | The role of Protein Tyrosine Phosphatase non-Receptor type 11 (PTPN11/Shp2) mutations in human non-small cell lung cancer (NSCLC) |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | Principal Investigator |
Patient Reviews
CV information above last modified April 24, 2024